New Insights into the Management & Treatment of VTE- Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis (DVT), a serious condition where blood clots develop deep in the veins and pulmonary embolism (PE). VTE is the most common potentially preventable form of hospital-related mortality in the United States. Prevention of VTE has been identified as one of the most important in-hospital safety practices in the United States. The VTE guidelines produced by the American College of Chest Physicians (ACCP) are consistently being updated to provide a framework for clinical practice and prophylaxis policies in VTE prevention, diagnosis and management. Implementation of guidelines and best practices for prevention, diagnosis, and management can potentially reduce the morbidity and mortality associated with VTE. Pharmacologic methods to prevent VTE are considered safe, effective, and cost-effective, yet studies continue to show that these preventive methods are underused. Managed care professionals need to understand the importance of risk assessment and VTE prevention through prophylaxis treatment, particularly for those undergoing total hip or knee replacement surgery, in order to improve patient outcomes. Additionally, healthcare professionals need to be aware of investigational, novel agents in development.
Discuss the challenges and barriers to improving outcomes in patients with VTE
Examine diagnostic measures regarding decisions on intensity and duration of treatment for VTE.
Assess individualization of anticoagulant therapy, including the choice of therapeutic agent, the route of administration, and the appropriate setting for treatment.
Analyze emerging evidence regarding the optimal management of VTE, including the selection of risk-appropriate anticoagulant therapy and ideal duration of treatment.
Evaluate the current evidence-based recommendations of novel oral anticoagulants to treat patients with VTE.1.0 Free CEUs for Nurses
Expires 3/31/16
